Endothelial monocyte activating polypeptide ii induces endothelial cell apoptosis and may inhibit tumor angiogenesis

Microvascular Research

Volumn 60, Issue 1, 2000, Pages 70-80

  Berger, Adam C ^a   Alexander, H Richard ^a   Tang, Guangquing ^a   Wu, Peter S ^a   Hewitt, Stephen M ^a   Turner, Ewa ^a   Kruger, Erwin ^a   Figg, William D ^a   Grove, Andrew ^a   Kohn, Elise ^a   Stern, David ^b   Libutti, Steven K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b The New York Presbyterian Hospital   (United States)

Author keywords

Angiogenesis; Apoptosis; EMAP II; Necrosis; Tumor

Indexed keywords

FAS ANTIGEN; POLYPEPTIDE; PROTEIN BCL 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VASCULARIZATION;

ANIMALIA;

EID: 0033947124     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.2000.2249     Document Type: Article

References (25)

1. Bocci G., Danesi R., Benelli U., Innocenti F., DiPaolo A., Fogli S., Del Tacca M. Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother. Pharmacol. 43:1999;205-212.
2. Choi K.-B., Wong F., Harlan J. M., Chaudhary P. M., Hood L., Karsan A. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J. Biol. Chem. 273:1998;20185-20188.
3. Folkman J. Tumor angiogenesis, therapeutic implications. N. Engl. J. Med. 285:1971;1182-1186.
4. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 339:1989;58-61.
5. Grant D. S., Lelkes P. I., Fukuda K., Kleinman H. K. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev. Biol. 27A:1991;327-336.
6. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
7. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 277:1997;48-50.
8. Kao J., Ryan J., Brett G., Chen J., Shen H., Fan Y.-G., Godman G., Familletti P., Wang F., Pan Y.-C., Stern D., Clauss M. Endothelial monocyte-activating polypeptide II, A novel tumor-derived polypeptide that activates host-response mechanisms. J. Biol. Chem. 267:1992;20239-20247.
9. Kao J., Houck K., Fan Y., Hzehnel I., Libutti S. K., Kayton M., Grikscheit T., Chabot J., Nowygrod R., Greenberg S., Kuang W.-J., Leung D., Hayward J., Kisiel W., Heath M., Brett J., Stern D. Characterization of a novel tumor-derived cytokine, endothelial-monocyte activating polypeptide II. J. Biol. Chem. 269:1994a;25106-25119.
10. Kao J., Fan Y.-G., Haehnel I., Brett J., Greenberg S., Clauss M., Kayton M., Houck K., Kisiel W., Seljelid R., Burnier J., Stern D. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response. J. Biol. Chem. 269:1994b;9774-9782.
11. Knies U. E., Behrensdorf H. A., Mitchell C. A., Deutsch U., Risau W., Drexler H. C. A., Clauss M. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc. Natl. Acad. Sci. USA. 95:1998;12322-12327.
12. Kohn E. C., Alessandro R., Spoonster J., Wersto R. P., Liotta L. A. Angiogenesis, role of calcium-mediated signal transduction. Proc. Natl. Acad. Sci. USA. 92:1995;1307-1311.
13. Laster S. M., Wood J. G., Gooding L. R. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141:1988;2629-2634.
14. Lawley T. J., Kubota Y. Induction of morphologic differentiation of endothelial cells in culture. J. Invest. Dermatol. 93:1989;59S-61S.
15. Lucas R., Holmgren L., Garcia I., Jimenez B., Mandriota S. J., Borlat F., Sim B. K., Wu Z., Grau G. E., Shing Y., Soff G. A., Bouck N., Pepper M. S. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood. 92:1998;4730-4741.
16. Marvin M., Libutti S. K., Kayton M., Kao J., Hayward J., Grikscheit T., Fan Y., Brett J., Weinberg A., Nowygrod R., LoGerfo P., Feind C., Hansen K., Schwartz M., Stern D., Chabot J. A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor. J. Surg. Res. 63:1996;248-255.
17. Polunovsky V. A., Wendt C. H., Ingbar D. H., Peterson M. S., Bitterman P. B. Induction of endothelial cell apoptosis by TNFα: Modulation by inhibitors of protein synthesis. Exp. Cell Res. 214:1994;584-594.
18. Reed J. C. Bcl-2 family proteins. Oncogene. 17:1998;3225-3236.
19. Robaye B., Mosselmans R., Fiers W., Dumont J. E., Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am. J. Pathol. 138:1991;447-457.
20. Schluesener H., Seid K., Zhao Y., Meyermann R. Localization of endothelial-monocyte-activating polypeptide II (EMAP), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis. Expression by monocytes and activated microglial cells. Glia. 20:1997;365-372.
21. Schwarz M. A., Kandel J., Brett J., Li J., Hayward J., Schwarz R. E., Chappey O., Wautier J. L., Chabot J., LoGerfo P., Stern D. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J. Exp. Med. 190:1999;341-353.
22. Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis, apoptosomes or mitochondria? Genes Cells. 3:1998;697-707.
23. Weidener N., Folkman J. Tumoral vascularity as a prognostic factor in cancer. Important Adv. Oncol. 1996;167-190.
24. Wu P. C., Berger A. C., Huang J., Gnant M., Turner E., Alexander H. R., Libutti S. K. In vivo tumors that overexpress endothelial monocyte-activating polypeptide II demonstrate upregulation of tumor necrosis factor receptor p55 on tumor neovasculature. Surg. Forum. XLIX:1998;436-438.
25. Wu P. C., Alexander H. R., Huang J., Hwu P., Gnant M., Berger A. C., Turner E., Wilson O., Libutti S. K. In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-α is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII). Cancer Res. 59:1999;205-212.